Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raja Seethala

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Molecular Cancer Research : MCR|December 17, 2008
Kinin b2 receptor mediates induction of cyclooxygenase-2 and is overexpressed in head and neck squamous cell carcinomasWeiping Zhang, Neil Bhola, Shailaja Kalyankrishna, et al.
Head and Neck Pathology|April 28, 2018
Measuring Depth of Invasion in Early Squamous Cell Carcinoma of the Oral Tongue: Positive Deep Margin, Extratumoral Perineural Invasion, and Other ChallengesJeremie Berdugo, Lester D R Thompson, Bibianna Purgina, et al.
Head & Neck|July 7, 2025
Magnifying Glass on Sinonasal NUT Carcinoma Heterogeneity via Spatial TranscriptomicsDiana Bell, Garret Choby, Michelle Afkhami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2011
Targeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximabNeil E Bhola, Sufi M Thomas, Maria Freilino, et al.
Diagnostic Cytopathology|March 9, 2018
Cancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid-stimulating hormone receptor gene mutationsSann Y Mon, Gregory Riedlinger, Collette E Abbott, et al.
Oral Oncology|September 6, 2011
Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancerAthanassios Argiris, Steve C Lee, Trevor Feinstein, et al.
Molecular Pharmacology|March 8, 2008
Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-X(L) enhances antitumor effects in squamous cell carcinoma of the head and neckAmanda L Boehm, Malabika Sen, Raja Seethala, et al.
Thyroid : Official Journal of the American Thyroid Association|July 25, 2022
Clinicopathologic Characteristics and Postsurgical Follow-Up of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in the Postnomenclature Revision EraCharit Taneja, Linwah Yip, Elena M Morariu, et al.
Human Pathology|July 8, 2008
Primary cardiac sarcomas: a clinicopathologic analysis of a series with follow-up information in 17 patients and emphasis on long-term survivalPaul J Zhang, John S Brooks, John R Goldblum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2021
Management of Salivary Gland Malignancy: ASCO GuidelineJessica L Geiger, Nofisat Ismaila, Beth Beadle, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Molecular Cancer Research : MCR|December 17, 2008
Kinin b2 receptor mediates induction of cyclooxygenase-2 and is overexpressed in head and neck squamous cell carcinomasWeiping Zhang, Neil Bhola, Shailaja Kalyankrishna, et al.
Head and Neck Pathology|April 28, 2018
Measuring Depth of Invasion in Early Squamous Cell Carcinoma of the Oral Tongue: Positive Deep Margin, Extratumoral Perineural Invasion, and Other ChallengesJeremie Berdugo, Lester D R Thompson, Bibianna Purgina, et al.
Head & Neck|July 7, 2025
Magnifying Glass on Sinonasal NUT Carcinoma Heterogeneity via Spatial TranscriptomicsDiana Bell, Garret Choby, Michelle Afkhami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2011
Targeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximabNeil E Bhola, Sufi M Thomas, Maria Freilino, et al.
Diagnostic Cytopathology|March 9, 2018
Cancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid-stimulating hormone receptor gene mutationsSann Y Mon, Gregory Riedlinger, Collette E Abbott, et al.
Oral Oncology|September 6, 2011
Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancerAthanassios Argiris, Steve C Lee, Trevor Feinstein, et al.
Molecular Pharmacology|March 8, 2008
Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-X(L) enhances antitumor effects in squamous cell carcinoma of the head and neckAmanda L Boehm, Malabika Sen, Raja Seethala, et al.
Thyroid : Official Journal of the American Thyroid Association|July 25, 2022
Clinicopathologic Characteristics and Postsurgical Follow-Up of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in the Postnomenclature Revision EraCharit Taneja, Linwah Yip, Elena M Morariu, et al.
Human Pathology|July 8, 2008
Primary cardiac sarcomas: a clinicopathologic analysis of a series with follow-up information in 17 patients and emphasis on long-term survivalPaul J Zhang, John S Brooks, John R Goldblum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 26, 2021
Management of Salivary Gland Malignancy: ASCO GuidelineJessica L Geiger, Nofisat Ismaila, Beth Beadle, et al.
Pageof 3